HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Parlux

This article was originally published in The Rose Sheet

Executive Summary

Chairman and CEO Ilia Lekach has withdrawn his offer to take the company private, fragrance company reports, noting it plans to file an 8-K with a copy of that notification. Following Lekach's unsolicited offer in June to pay $29 per share, an independent committee of the firm's board of directors responded it was not "prudent" to accept the offer due to "significant financial and other contingencies contained in the proposal" (1"The Rose Sheet" June 19, 2006, In Brief and 2"The Rose Sheet" July 3, 2006, In Brief). Parlux also confirms it has received offers for certain of its brands, and that the offers are being reviewed by the firm's board of directors. Company has not entered into definitive agreements regarding any of the offers, firm notes. Parlux holds the fragrance licenses to brands such as Paris Hilton, Perry Ellis, GUESS?, Maria Sharapova and Ocean Pacific...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014092

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel